Meeting
2024 ASCO Breakthrough
Analysis of heterochromatin remodeling as a mechanism of radiotherapy (RT) resistance through molecular profiling of radioresistant (RR) head and neck (HNC) and prostate cancers (PCa).
Authors
Evelyn Tan
National Cancer Centre Singapore, Singapore, Singapore
Evelyn Tan , Chaw Yee Beh , Celestia P.X. Yeo , Boon Hao Hong , Dennis J.J. Poon , Dewi Susanti , Eugenia Li Ling Yeo , Pek Lim Chu , Melvin L.K. Chua
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Thoracic Cancers,Breast Cancer,Gynecologic Cancer,Head and Neck Cancer,Hematologic Malignancies,Genetics/Genomics/Multiomics,Healthtech Innovations,Models of Care and Care Delivery,Viral-Mediated Malignancies,Other Malignancies or Topics
Sub Track
Early Detection and Surveillance
Citation
J Clin Oncol 42, 2024 (suppl 23; abstr 137)
DOI
10.1200/JCO.2024.42.23_suppl.137
Abstract #
137
Poster Bd #
E2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Genomic analysis to elucidate similarities and differences between primary colorectal cancers and colorectal cancer liver metastases.
First Author: Steven Allen Buechler
Poster
2022 ASCO Annual Meeting
Characterization of MET exon 14 skipping alterations (METex14) in non–small cell lung cancer (NSCLC) using whole transcriptome sequencing (WTS).
First Author: So Yeon Kim
Poster
2022 ASCO Genitourinary Cancers Symposium
A genomic classifier for prostate cancer correlates with adverse pathologic features: Transcriptomic features of cribriform and intraductal carcinoma of the prostate.
First Author: Zaeem M Lone